Altre lingue Pliant Therapeutics, Inc.

Azioni

PLRX

US7291391057

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 10/06/2024			Variaz. 5gg	Var. 1 gen.
11,51 ^USD	+3,23%		-4,48%	-36,44%

14/05	Aggiornamento settoriale: i titoli del settore sanitario calano nelle contrattazioni di martedì pomeriggio	MT
14/05	Pliant Therapeutics riporta dati topline positivi nello studio sulla fibrosi polmonare idiopatica	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Pliant Therapeutics Presents Data from its Bexotegrast Program at the European Association for the Study of the Liver (EASL) International Liver Congress™	06/06
Pliant Therapeutics Presents Data from its Bexotegrast Program at the American Thoracic Society International Conference	22/05
Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading	14/05
Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial	14/05
Pliant Therapeutics : Phase 2a PET Imaging Trial	14/05
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis	14/05
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis	14/05
Pliant Therapeutics, Inc. Announces Positive Topline Data from A Phase 2A Collagen Pet Imaging Clinical Trial of Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis	14/05
Pliant Therapeutics Announces Upcoming Presentations at the European Association for the Study of the Liver International Liver Congress™	07/05
Pliant Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	06/05
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	06/05
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results	06/05
Pliant Therapeutics to Participate in Upcoming Investor Events	01/05
Pliant Therapeutics to Participate in Upcoming Investor Events	01/05
Pliant Therapeutics to Participate in Upcoming Investor Events	02/04
Pliant Therapeutics Announces Upcoming Presentations at the 2024 American Thoracic Society International Conference	27/03
Nimbus Therapeutics Appoints Katharine Knobil, M.D., to Board of Directors	13/03
Pliant Therapeutics, Inc. Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis	12/03
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis	12/03
Pliant Therapeutics Announces Accelerated Bexotegrast Development Plan for the Treatment of Idiopathic Pulmonary Fibrosis	12/03

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Pliant Therapeutics, Inc.

Azioni

PLRX

US7291391057

Altre lingue

Filtri